Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

When Epidemics Collide: Why People With Human Immunodeficiency Virus May Have Worse Coronavirus Disease 2019 Outcomes and Implications for Vaccination
Virginia A. Triant, Rajesh T. Gandhi
Clinical Infectious Diseases (2020) Vol. 72, Iss. 12, pp. e1030-e1034
Open Access | Times Cited: 19

Showing 19 citing articles:

Willingness to accept COVID-19 vaccination among people living with HIV in a high HIV prevalence community
Sabina Govere-Hwenje, Jana Jarolimova, Joyce Yan, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 31
Human Immunodeficiency Virus/AIDS in the Era of Coronavirus Disease 2019: A Juxtaposition of 2 Pandemics
Robert W. Eisinger, Andrea M. Lerner, Anthony S. Fauci
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 9, pp. 1455-1461
Open Access | Times Cited: 36
Vaccination hesitancy and the “myth” on mRNA‐based vaccines in Italy in the COVID‐19 era: Does urgency meet major safety criteria?
Salvatore Chirumbolo
Journal of Medical Virology (2021) Vol. 93, Iss. 7, pp. 4049-4053
Open Access | Times Cited: 32
Immune response and safety to inactivated COVID-19 vaccine: a comparison between people living with HIV and HIV-naive individuals
Shi Zou, Mengmeng Wu, Fangzhao Ming, et al.
AIDS Research and Therapy (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 25
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2
Francisco Javier Candel, Pablo Barreiro, Miguel Salavert, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1449-1449
Open Access | Times Cited: 11
Predictors of COVID-19 Vaccine Acceptability among Patients Living with HIV in Northern Nigeria: A Mixed Methods Study
Zubairu Iliyasu, Aminatu A. Kwaku, Amina A. Umar, et al.
Current HIV Research (2021) Vol. 20, Iss. 1, pp. 82-90
Closed Access | Times Cited: 22
Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency – Three consecutive cases and review of the literature
Marcial Delgado‐Fernández, Gracia Mar García-Gemar, Ana Fuentes, et al.
Enfermedades Infecciosas y Microbiología Clínica (2021) Vol. 40, Iss. 9, pp. 507-516
Open Access | Times Cited: 21
COVID-19 Outcomes Among People With HIV and COVID-19 in New York City
Sarah Braunstein, Amanda Wahnich, Rachael Lazar
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 11, pp. 1571-1582
Open Access | Times Cited: 8
Mitigating Isolation of People Aging With HIV During the COVID-19 Pandemic
Brandon Brown, Jeff Taylor, Celia B. Fisher
Public Health Reports (2021) Vol. 136, Iss. 4, pp. 394-396
Open Access | Times Cited: 12
ChAdOx1 nCoV-19 (AZD1222) Vaccine in People Living With and Without HIV
Shabir A. Madhi, Anthonet Koen, Lee Fairlie, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 9
Short Communication: Coronavirus Disease 19 Among People Living with HIV in Western India: An Observational Cohort Study
Sanjay Pujari, Sunil Gaikwad, Abhishek Chitalikar, et al.
AIDS Research and Human Retroviruses (2021) Vol. 37, Iss. 8, pp. 620-623
Closed Access | Times Cited: 9
Willingness to accept COVID-19 vaccination among people living with HIV in a high HIV prevalence community
Sabina Govere-Hwenje, Jana Jarolimova, Joyce Yan, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 6
Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency – Three consecutive cases and review of the literature
Marcial Delgado‐Fernández, Gracia Mar García-Gemar, Ana Fuentes, et al.
Enfermedades infecciosas y microbiologia clinica (English ed ) (2022) Vol. 40, Iss. 9, pp. 507-516
Open Access | Times Cited: 6
CD4 + Count: a Variable to Be Considered to Prioritize COVID-19 Vaccination in PLHIV
Vakada Lakshmi Mounika, Vikash Kumar, Sameer Dhingra, et al.
Current Pharmacology Reports (2023) Vol. 9, Iss. 2, pp. 90-97
Open Access | Times Cited: 3
Case 40-2023: A 70-Year-Old Woman with Cough and Shortness of Breath
Rajesh T. Gandhi, Alison Castle, Túlio de Oliveira, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 26, pp. 2468-2476
Open Access | Times Cited: 3
The impact of coronavirus disease 2019 on people with HIV
Julia del Amo, Asunción Díaz, Rosa Polo
Current Opinion in Infectious Diseases (2021) Vol. 35, Iss. 1, pp. 9-14
Closed Access | Times Cited: 7
Rates and determinants of COVID-19 vaccine uptake among people living with HIV in Federal Capital Territory, Nigeria
Victoria Etuk, Charity Sanni, Oluwatosin Adejumoke Omonijo, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2024)
Open Access
COVID-19 vaccination in adults living with HIV
Christopher W. Blackwell, Humberto López Castillo
Journal of the American Association of Nurse Practitioners (2021) Vol. 34, Iss. 3, pp. 604-609
Open Access | Times Cited: 2
COVID-19 Outcomes Among People With HIV and COVID-19 in New York City
Sarah Braunstein, Amanda Wahnich, Rachael Lazar
SSRN Electronic Journal (2022)
Closed Access
Page 1

Scroll to top